Other Indications for Prone Positioning
Beyond the established indication for invasively ventilated ARDS patients with PaO₂/FiO₂ < 150 mmHg, prone positioning should be considered for: (1) awake non-intubated patients with COVID-19 and acute hypoxic respiratory failure, (2) ARDS patients on veno-venous ECMO, and (3) selected patients following abdominal surgery or with abdominal pathologies after careful risk-benefit assessment 1.
Primary Alternative Indications
Awake Prone Positioning in COVID-19
The most strongly supported alternative indication is awake proning in non-invasively ventilated patients with COVID-19 and acute hypoxic respiratory failure (Level 1 evidence) 1. This represents a strong recommendation based on high-quality evidence showing improved oxygenation and reduced need for intubation 2, 3.
Important caveat: For non-COVID-19 patients requiring non-invasive ventilation, the evidence remains insufficient to make a recommendation for or against awake proning 1. The optimal duration of awake proning also remains undefined 1.
ARDS Patients on VV-ECMO
Prone positioning is suggested for ARDS patients receiving veno-venous ECMO therapy (Level 2 evidence) 1. This represents an emerging indication where prone positioning may provide additional benefit even when extracorporeal support is already in place 4.
Special Populations Requiring Individual Assessment
Post-Abdominal Surgery and Abdominal Pathologies
Prone positioning should be considered (not routinely applied) in patients following abdominal surgery, those with abdominal pathologies, or abdominal obesity, but only after individual risk-benefit analysis (Level 4 evidence) 1.
The decision algorithm should weigh:
- Potential benefit: Improvement in oxygenation
- Potential risks: Increased intraabdominal pressure leading to surgical complications, acute renal failure, or hypoxic hepatitis
This requires interdisciplinary discussion involving surgical and critical care teams 1.
Emerging Evidence for Non-ARDS Hypoxemic Respiratory Failure
Recent evidence suggests prone positioning may benefit non-intubated patients with hypoxemic respiratory failure unrelated to ARDS 2. A 2026 meta-analysis demonstrated that in non-intubated non-ARDS patients, prone positioning:
- Improved PaO₂/FiO₂ ratio (mean difference: -51.36 mmHg)
- Decreased need for intubation (RR: 0.74)
- Showed a trend toward improved mortality (RR: 0.81)
However, this remains investigational and not yet incorporated into formal guidelines.
Absolute and Relative Contraindications
Even when considering alternative indications, prone positioning should only be performed after interdisciplinary risk-benefit assessment when these contraindications exist 1:
- Open abdomen
- Spinal instability
- Increased intracranial pressure (requires continuous ICP monitoring if attempted, with head in centered position) 1
- Cardiac arrhythmias with hemodynamic consequences
- Shock
Critical implementation point: Hemodynamic stabilization and volume optimization should precede prone positioning, though catecholamine use is not an absolute contraindication 1.
Key Practical Considerations
When implementing prone positioning for any indication:
- Duration: Minimum 12 hours, preferably 16 hours per session 1
- Completeness: Full 180° prone positioning is superior to incomplete positioning 1
- Monitoring: Careful examination for pressure ulcers during positioning 1
- Discontinuation criteria: Consider stopping if oxygenation improvement persists 4 hours after repositioning (PaO₂/FiO₂ ≥ 150 with PEEP ≤ 10 cm H₂O and FiO₂ ≤ 0.6) or after two unsuccessful attempts 1
The 2024 Intensive Care Medicine guideline represents the most comprehensive and recent evidence synthesis on this topic 1, superseding older recommendations from the 2017 Surviving Sepsis Campaign 5 and 2017 ATS guidelines 6.